The Military Threat to R&D

One needn't be opposed to defense spending to decry the disproportionate allocation of federal R&D funds that has gone to the military sector during the Reagan administration. The administration's budget request for fiscal year 1988 would bring to 72 percent the share of federal research dollars earmarked for defense-related programs. But a roughly three-fourths portion for military R&D is historically anomalous: from 1965 to 1980, the federal pie for R&D was divided about equally between defens

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The administration's budget request for fiscal year 1988 would bring to 72 percent the share of federal research dollars earmarked for defense-related programs. But a roughly three-fourths portion for military R&D is historically anomalous: from 1965 to 1980, the federal pie for R&D was divided about equally between defense and civilian programs.

In 1981 federal spending for civilian R&D amounted to $15.3 billion while military R&D received $17 billion. In the administration's 1988 request, however, civilian R&D would receive $18 billion and military R&D would total $46 billion—a nearly three-fold increase from the 1981 level. With respect to last year's budget, the 1988 request represents a 16.8 percent increase for military R&D but only a 2.8 percent increase for civilian R&D.

During the current appropriations process, the Congress will rechannel some funds from the defense to the civilian sector, as it has in the past. In particular, the administration's $5.7 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo